<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR57">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moniot</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Forgione</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Lucidi</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Hailu</surname>
    <given-names>GS</given-names>
   </name>
   <name>
    <surname>Nebbioso</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Carafa</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Pellicciari</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <article-title>Development of 1, 2, 4-oxadiazoles as potent and selective inhibitors of the human deacetylase sirtuin 2: structureâ€“activity relationship, X-ray crystal structure, and anticancer activity</article-title>
  <source>J Medical Chemistry</source>
  <year>2017</year>
  <volume>60</volume>
  <issue>6</issue>
  <fpage>2344</fpage>
  <lpage>2360</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b01609</pub-id>
 </element-citation>
</ref>
